Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Patheon Opens New Milton Park Development Facility | Contract Pharma
Breaking News

Patheon Opens New Milton Park Development Facility

Patheon has opened its new early phase development facility in Milton Park in Oxfordshire, UK. The 13,500-sq.-ft development facility has newly constructed formulation labs and a fully equipped analytical lab. The facility will focus on the early phase development of solid, semi-solid and oral liquid dosage forms, and includes GMP manufacturing areas for the production of clinical trial materials for Phase I/II trials. The company’s Quick To Clinic programs, which work to accelerate molecules to clinical trials while minimizing API requirements, will be supported at the site. The facility holds an Investigational Medical Product License from the MHRA (UK).
   
“The Milton Park facility was created to meet our customers’ growing demand for rapid early phase development capacity in a strategic location”, said Norman Barras vice-president, Pharmaceutical Development Services, Europe. “We believe that our Quick to Clinic(TM) approach will provide a valuable opportunity to shorten the development times of our customers’ projects.”
   
“Milton Park is one of many significant additions that we plan to make in our development service offerings”, added Wes Wheeler, chief executive officer. “We are constantly striving to understand our customers’ needs and then respond accordingly.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters